HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan
· Delayed Price · Currency is TWD 63.50
-0.80 (-1.24%)
Apr 29, 2026, 11:49 AM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.96 billion as of April 28, 2026. Its market cap has decreased by -23.36% in one year.
Market Cap
2.96B
Enterprise Value
2.48B
Revenue
293.23M
Ranking
n/a
PE Ratio
26.46
Stock Price
63.50
Market Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.96B, a decrease of -28.87%. That is a compound annual growth rate of -12.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.96B | 2.06% |
| Dec 31, 2025 | 2.90B | -6.67% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BRIM Biotechnology | 3.08B |
| Apex Biotechnology | 2.84B |
| SYN-TECH Chem. & Pharm. | 3.15B |
| Syngen Biotech | 2.78B |
| Genovate Biotechnology | 3.19B |
| 3D Global Biotech | 2.76B |
| Intech Biopharm | 3.23B |
| Shine-On BioMedical | 3.28B |